971.0 - Poisoning By Parasympathomimetics (cholinergics)
The ICD 9 Code for
Poisoning by parasympathomimetics (cholinergics) is listed as
971.0. Additional information concerning this code and description can be found below including ICD 10 crosswalks / GEMS, and chapter information where available.
| ICD 9 CM Field |
Value |
| Diagnosis Code: |
971.0 |
| Long Description: |
Poisoning by parasympathomimetics (cholinergics) |
| Short Description: |
Pois-parasympathomimetic |
|
|
| Chapter: |
Injury And Poisoning |
| Block: |
Poisoning By Drugs, Medicinals And Biological Substances (960-979) |
| ICD-10-CM Diagnosis Codes General Equivalence Mappings (GEMS): |
|---|
| ICD-10-CM Code: |
T44.0X1A - Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter (approximate) |
| ICD-10-CM Code: |
T44.0X2A - Poisoning by anticholinesterase agents, intentional self-harm, initial encounter (approximate) |
| ICD-10-CM Code: |
T44.0X3A - Poisoning by anticholinesterase agents, assault, initial encounter (approximate) |
| ICD-10-CM Code: |
T44.0X4A - Poisoning by anticholinesterase agents, undetermined, initial encounter (approximate) |
| ICD-10-CM Code: |
T44.1X1A - Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter (approximate) |
| ICD-10-CM Code: |
T44.1X2A - Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter (approximate) |
| ICD-10-CM Code: |
T44.1X3A - Poisoning by other parasympathomimetics [cholinergics], assault, initial encounter (approximate) |
| ICD-10-CM Code: |
T44.1X4A - Poisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter (approximate) |
| ICD-9-CM Siblings (same level / similar specificity) of 971.0: |
|---|
| 971.1 - Poisoning by parasympatholytics (anticholinergics and antimuscarinics) and spasmolytics |
| 971.2 - Poisoning by sympathomimetics [adrenergics] |
| 971.3 - Poisoning by sympatholytics [antiadrenergics] |
| 971.9 - Poisoning by unspecified drug primarily affecting autonomic nervous system |
